5 hours ago
AbbVie Announces TEPKINLY® in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for the treatment of relapsed or refractory follicular lymphoma in the second-line setting, offering a chemotherapy-free... Read more.
Owner: Irish Government through Coimisiún na Meán
Owner: Saudi Government through Saudi National Bank (a.k.a. Al Ahli Capital or National Commercial Bank Funds) 4 & 13 through Saudi Research & Media Group
Owner: Nabeel Al-Hamar through ALAYAM Publishing Group
More from Investing News Network
Owner: Nick Smith (CEO) through Investing News Network
Owner: Nick Smith (CEO) through Investing News Network
Owner: Nick Smith (CEO) through Investing News Network
Search & Explore
Search the news with more context, not more noise.
Today's Media Watch
Your daily guide to the stories shaping media, journalism, and public trust.
Who Owns the Narrative?
See the impact of media framing through real-world case studies.
The EU-Mercosur
Free-trade agreements divide opinion. The EU-Mercosur deal sparked conflicting headlines, reflecting debates over prices, industry, environment, and self-sufficiency.
COVID Vaccinations
This analysis of COVID vaccination coverage shows how ideology, ownership, and political framing shape media narratives, influencing both what we think and how we think.
Greenland
This case study explores the Greenland acquisition scenario as a real-world media literacy stress test, revealing how ideology, ownership, and political framing shape the stories we consume.
Learn About Our Fact-Based Transparency System
Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.
Learn more
